I couldn‚Äôt find any **reliable official pharmacological data** (from regulatory agencies, peer-reviewed drug monographs or standard pharmacopeias) for a medicine called *Koramin* described as a ‚Äúcomplex of proteins and nucleoproteins.‚Äù It appears that **what you are referring to as ‚ÄúKoramin‚Äù is not a recognized approved pharmaceutical in major databases**, but rather a *dietary supplement / peptide bioregulator* marketed (primarily in some Eastern-European/Russian-Federation supplement contexts) with claimed effects. ([e-peptide.com][1])

Below is everything that can be **factually ascertained**, clearly separating what is **established pharmacology** versus what is **unverified marketing claims**.

---

## üß¨ 1. What *Koramin* (Peptide Bioregulator) Is

*Koramin* (also spelled *Coramin* in some sources) in the supplement context is described as:

* A **natural peptide bioregulator** ‚Äî a complex of short peptides (proteins) and nucleoproteins extracted from **cardiac tissue of young animals**. ([e-peptide.com][1])
* Sold as a **dietary supplement**, not an approved pharmaceutical in European or US regulatory drug databases.
* Typically presented for **cardiovascular support** and **regeneration** in promotional materials.

> **Important:** There are *no standard pharmacopeial entries, regulatory labels (like FDA or EMA product monographs), or clinical pharmacokinetics studies* for this product. Any detailed pharmacological parameters in the literature are therefore *not established science*.

---

## ‚öñÔ∏è 2. Claimed Pharmacological Actions ‚Äî *Marketing / Supplement Claims*

According to supplement product descriptions:

### Primary Effects Claimed

These therapeutic effects are *claimed* but **not validated** in standard clinical pharmacology literature:

1. **Selective support of cardiac muscle cells** ‚Äî targeting heart function. ([e-peptide.com][1])
2. **Improvement of myocardial resilience** to ischemia and stress (claimed). ([e-peptide.com][1])
3. **Normalization of contractile function** of the heart. ([e-peptide.com][1])
4. **Reduction of angina frequency and duration** (claimed). ([e-peptide.com][1])
5. **Support for recovery after myocardial infarction** and cardiac injury (claimed). ([e-peptide.com][1])
6. **Improvement of exercise tolerance and energy use** in cardiac tissues (claimed). ([e-peptide.com][1])

> ‚ö†Ô∏è These effects come from **marketing and supplement vendors** ‚Äî they do *not represent established pharmacological actions recognized by regulatory drug authorities*. No validated mechanism of action, receptor targets, or clinical efficacy data are publicly documented in major scientific sources.

---

## üìâ 3. Pharmacokinetic Parameters ‚Äî **No Reliable Data**

There are **no verified pharmacokinetic studies** (such as blood level time-courses, half-life, absorption, metabolism, distribution, excretion) for *Koramin* as a specific product.

### What *would* be expected for peptide complexes

**General principles for orally administered peptides:**

* **Bioavailability:** Peptides taken orally are generally poorly bioavailable because:

  * They are degraded by digestive enzymes.
  * They are not specifically engineered for absorption like peptide drugs (e.g., insulin analogues). ([fr.iliveok.com][2])

* **Half-life:** Short peptides typically have very **short plasma half-lives** (minutes to low hours) unless chemically modified/protected ‚Äî but *no data exist for Koramin itself*.

* **Distribution:** If absorbed, small peptides might circulate briefly then be broken down to amino acids ‚Äî but again, **no data** exist.

**Conclusion on pharmacokinetics:**
üëâ There is **no reliable half-life figure, bioavailability data (oral or otherwise), or published metabolism/elimination profile** for this product.

---

## üíä 4. Dosage Information ‚Äî From Supplement Labels

Since *Koramin* is marketed as a supplement and not an approved drug, dosage ranges are based on vendor recommendations, not clinical trials:

### Typical Supplement Dosage

* **Form:** Capsule or tablet, ~155 mg (peptide/nucleoprotein complex). ([e-peptide.com][1])
* **Suggested dose:**

  * **1‚Äì3 capsules/tablets**, **2‚Äì3 times daily**,
  * **10‚Äì15 min before meals**,
  * **for 10‚Äì15 days per course**. ([e-peptide.com][1])
* **Repeat courses:** Often marketed for repetition after **3‚Äì6 months**. ([e-peptide.com][1])

‚ö†Ô∏è These recommendations are **not clinically validated dosing ranges**, and there is no **minimum effective dose** or **maximum safe dose** with established safety data in either healthy or disease populations.

---

## üìä 5. Safety and Side Effects ‚Äî **Not Officially Studied**

There are **no systematic safety studies** published for this product. Therefore:

* **Adverse reactions** and **toxicity profiles** are *unknown*.
* **Interactions** with medications (e.g., cardiovascular drugs, anticoagulants) are *unknown*.
* **Contraindications** and **special populations (pregnancy, kidney disease, etc.)** are *not established*.

Clinically approved products generally have extensive safety data; such data are *not available* for this product.

---

## üìå Summary of What *Is and Is Not* Established

| Category               | Established                                 | Not Established                     |
| ---------------------- | ------------------------------------------- | ----------------------------------- |
| Pharmacological action | *None recognized in official pharmacopeias* | Mechanism of action                 |
| Clinical efficacy      | *None validated by clinical trials*         | Effect sizes                        |
| Pharmacokinetics       | *General peptide principles exist*          | Half-life, bioavailability          |
| Dosage ranges          | *Vendor recommendations only*               | Safe/efficacious therapeutic dosage |
| Safety profile         | *No regulated data*                         | Side effects, drug interactions     |

---

## ‚ö†Ô∏è Final Conclusion (Evidence-Based)

‚û°Ô∏è **Koramin (peptide bioregulator)** is *not recognized* in major pharmacological references as an approved drug.
‚û°Ô∏è **No scientifically validated pharmacological actions, half-life values, bioavailability, or dosage data** exist in peer-reviewed or regulatory sources.
‚û°Ô∏è All described actions and doses are from *supplement marketing claims*, not established pharmacology.

---

If you want, I **can help find evidence-based peptide drugs with documented pharmacokinetics and mechanisms** that are truly used in cardiovascular or regenerative medicine ‚Äî just let me know what specific condition or purpose you‚Äôre interested in.

[1]: https://e-peptide.com/diseases-of-the-cardiovascular-system/coramin-cardiac-muscle-cytamin-detail?utm_source=chatgpt.com "coramin classic - cardiac muscle cytamin"
[2]: https://fr.iliveok.com/health/des-medicaments-qui-ameliorent-les-performances_106772i15828.html?utm_source=chatgpt.com "M√©dicaments am√©liorant les performances: instructions et noms"
